Proteomics

Dataset Information

0

Phosphoproteomics of Human ACHN cells by estrogen


ABSTRACT: To find out the potential targets in response to estrogen treatment on ACHN cell, a human renal cell carcinoma (RCC) cell line. Since estrogen can repress ACHN growth in a partly estrogen receptor-dependent manner, it is possible that phosphorylation state in ACHN cells is regulated.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Renal Cell Carcinoma

SUBMITTER: Wei-Chi Ku  

LAB HEAD: Wei-Chi Ku

PROVIDER: PXD001962 | Pride | 2016-04-26

REPOSITORIES: Pride

altmetric image

Publications

Dual Roles of 17-β Estradiol in Estrogen Receptor-dependent Growth Inhibition in Renal Cell Carcinoma.

Chen Kuo-Chiang KC   Lin Chih-Ming CM   Huang Chi-Jung CJ   Chen Shao-Kuan SK   Wu Sheng-Tang ST   Chiang Han-Sun HS   Ku Wei-Chi WC  

Cancer genomics & proteomics 20160501 3


<h4>Background</h4>It has been proposed that 17-β-estradiol (E2) activates estrogen receptor and inhibits renal cell carcinoma (RCC) growth. In the present study we explored the role of E2 and ER in the regulation of RCC growth.<h4>Materials and methods</h4>The RCC cell line ACHN was treated by E2 combining with E2 antagonist Fulvestrant or ER knockdown, and cell growth was monitored. Quantitative phosphoproteomics was applied to study the E2 regulated non-genomic phosphorylation changes. Wester  ...[more]

Similar Datasets

2020-08-07 | PXD011020 | Pride
2015-09-22 | PXD001264 | Pride
2017-01-17 | PXD000646 | Pride
2015-09-22 | PXD001298 | Pride
2015-09-22 | PXD001263 | Pride
2016-08-10 | PXD001473 | Pride
2016-07-09 | PXD000868 | Pride
2017-10-30 | PXD002805 | Pride
2018-10-26 | PXD003522 | Pride
2024-03-26 | PXD046446 | Pride